Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

The amount of time Wegovy remains in your system depends on the dosage and how long you have been taking the medication, with the drug potentially being detectable for up to 5 to 7 weeks after the ...

Wegovy is a prescription medicine used for weight loss, to reduce cardiovascular risks, and to treat metabolic dysfunction-associated steatohepatitis (MASH). It is available in two forms: a liquid for ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

'It's not an easy pill to take': The first highly anticipated GLP-1 pill is here, but physicians aren't sure it has the staying power of the injections Once you take the Wegovy pill in the morning, ...

GP practices in England are to be incentivised to prescribe the weight loss drug Mounjaro to patients from April 2026 so that more people are able to benefit from it. Patients who are prescribed ...

You may have done your research and settled on Wegovy for weight management or cardiovascular health. Now what? Telemedicine options might be your ticket to fulfill the prescription, deliver it ...